Christina Sul
Overview
Explore the profile of Christina Sul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Posey J, Jordan M, Lewis C, Sul C, Dobrinskikh E, Swindle D, et al.
Blood Adv
. 2024 Dec;
PMID: 39693512
Inflammation drives the initiation and progression of pulmonary hypertension (PH). Platelets, increasingly recognized as immune cells, are activated and increased in the lungs of patients with PH. Platelet activation leads...
2.
Increased Circulating Extracellular Superoxide Dismutase Attenuates Platelet-Neutrophil Interactions
Sul C, Lewis C, Posey J, Jordan M, Hidalgo D, Porfilio T, et al.
Am J Respir Cell Mol Biol
. 2024 Nov;
PMID: 39531632
Acute respiratory distress syndrome (ARDS) is a serious illness accounting for 10% of ICU admissions and high mortality of 31-45% with a paucity of pharmacologic treatment options. Dysregulated inflammation and...
3.
Lewis C, Garcia A, Burciaga S, Posey J, Jordan M, Nguyen T, et al.
Physiol Genomics
. 2024 Sep;
56(11):776-790.
PMID: 39311838
The extracellular isoform of superoxide dismutase (SOD3) is decreased in patients and animals with pulmonary hypertension (PH). The human R213G single-nucleotide polymorphism (SNP) in SOD3 causes its release from tissue...
4.
Hidalgo D, Jordan M, Posey J, Burciaga S, Nguyen T, Sul C, et al.
Antioxidants (Basel)
. 2024 Aug;
13(8).
PMID: 39199221
Pulmonary hypertension (PH) is a progressive disease marked by pulmonary vascular remodeling and right ventricular failure. Inflammation and oxidative stress are critical in PH pathogenesis, with early pulmonary vascular inflammation...
5.
Sul C, Nozik E, Malainou C
Am J Respir Cell Mol Biol
. 2024 May;
71(1):18-20.
PMID: 38701437
No abstract available.
6.
Roy R, Allawzi A, Burns N, Sul C, Rubio V, Graham J, et al.
FASEB J
. 2023 Nov;
37(12):e23316.
PMID: 37983890
Alveolar inflammation is a hallmark of acute lung injury (ALI), and its clinical correlate is acute respiratory distress syndrome-and it is as a result of interactions between alveolar type II...
7.
Vaughn A, Lehmann T, Sul C, Wallbank A, Lyttle B, Bardill J, et al.
Pharmaceutics
. 2023 Sep;
15(9).
PMID: 37765178
Acute respiratory distress syndrome (ARDS) has approximately 40% in-hospital mortality, and treatment is limited to supportive care. Pneumonia is the underlying etiology in many cases with unrestrained inflammation central to...
8.
Sul C, Lewis C, Dee N, Burns N, Oshima K, Schmidt E, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Feb;
324(4):L445-L455.
PMID: 36749572
Acute respiratory distress syndrome (ARDS) remains a significant cause of morbidity and mortality in critically ill patients. Oxidative stress and inflammation play a crucial role in the pathogenesis of ARDS....
9.
Vohwinkel C, Burns N, Coit E, Yuan X, Vladar E, Sul C, et al.
JCI Insight
. 2022 Nov;
7(24).
PMID: 36326834
Acute lung injury (ALI) is a severe form of lung inflammation causing acute respiratory distress syndrome in patients. ALI pathogenesis is closely linked to uncontrolled alveolar inflammation. We hypothesize that...
10.
Ohlstrom D, Sul C, Vohwinkel C, Hernandez-Lagunas L, Karimpour-Fard A, Mourani P, et al.
Sci Rep
. 2022 Aug;
12(1):14560.
PMID: 36028738
Acute respiratory distress syndrome is a heterogeneous pathophysiological process responsible for significant morbidity and mortality in pediatric intensive care patients. Diagnosis is defined by clinical characteristics that identify the syndrome...